Nephronomics Atlas Discovery

About Nephronomics

Nephronomics is a private, pre-clinical stage biotech leveraging a unique data asset—the Nephronomics Atlas—built on a foundation of over 35,000 patient records and biospecimens from Fresenius Medical Care's 'My Reason' program. The company applies AI and whole genome sequencing to deconstruct heterogeneous renal diseases into precise molecular subtypes for novel therapeutic discovery and patient stratification. Its business model combines platform-driven target discovery with therapeutic development, positioning it at the intersection of big data, diagnostics, and drug development in the high-need nephrology space.

Therapeutic Areas